In agreement with this set of previous data we found that in a model of primary mammary carcinogenesis driven by Her2, an oncogene involved in human breast cancer, ACKR2 deficiency was associated with accelerated appearance and growth of primary lesions. This evidence concerns the gene ACKR2 and breast cancer.